Serum levels of ifabp2 and differences in lactobacillus and porphyromonas gingivalis abundance on gut microbiota are associated with poor therapeutic response in rheumatoid arthritis: a pilot study

HIGHLIGHTS

• who: Oscar Zaragoza-Garcu00eda and collaborators from the Faculty of Chemical-Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Mexico have published the research work: Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study, in the Journal: (JOURNAL) of 21/Dec/2022
• what: The aims of this study were to analyze the effect of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) on the of gut microbiota`s bacteria; to evaluate the relationship between the differences in microbial . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.